Diagnostic Products And Minerva Sign Development Agreement

Diagnostic Products Corp. and Minerva Pharmaceuticals Inc. have entered into a license agreement for the development of immunoassays for a newly described malignancy protein. Minerva Pharmaceuticals is a privately held Baltimore-based company formed for the purpose of commercialising platform technology licensed from the University of Maryland. Minerva founding scientists discovered that altered components of the Read more about Diagnostic Products And Minerva Sign Development Agreement[…]